Daiichi Sankyo To Start Phase III Nimotuzumab Trials In Japan For Gastric, Lung Cancer

  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Japan

More from Focus On Asia